Summary:
Click image to enlargeA phase 4 clinical research study to assess the potential effects of adding methotraxate to Krystexxa® (pegloticase) treatment to manage uncontrolled gout in adults.
Qualified Participants Must:
• Be 18+ years old
•
Have uncontrol gout
•
Be willing and able to give informed consent
Qualified Participants May Receive:
Participants will receive all study-related care and study drug at no cost. Reimbursement for time and travel related to study may be available as well.